PRC2-INHIBITOREN
European patent · EP3746446 · In force
Register entry
- Publication number
- EP3746446
- Application number
- EP19710816
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jan 29, 2019
- Published
- Dec 9, 2020
- Granted
- May 11, 2022
- Protection ends at the latest
- Jan 28, 2039
- Next annual fee due
- Jan 31, 2027
- IPC classes
- C07D 487/04 (2006.01)A61P 35/00 (2006.01)A61K 31/519 (2006.01)
- Priority
- US 201862624176 P 31.01.2018US 201862672701 P 17.05.2018US 201862747736 P 19.10.2018
- PCT application
- PCT/US2019/015677 29.01.2019
- PCT publication
- WO2019/152419 08.08.2019
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Feb 1, 2026
Change
Published in Swissreg on 01.02.2026
- Feb 1, 2025
Change
Published in Swissreg on 01.02.2025
- Oct 29, 2024
Holder’s address changed
- Owner
- Mirati Therapeutics, Inc., 3545 Cray Court, San Diego, CA 92121, USA → Mirati Therapeutics, Inc., Route 206 and Province Line Road, Princeton, New Jersey 08543, USA
Published in Swissreg on 29.10.2024
- Feb 1, 2024
Change
Published in Swissreg on 01.02.2024
- Mar 22, 2023
Change
Published in Swissreg on 22.03.2023
- Feb 1, 2023
Change
Published in Swissreg on 01.02.2023
- Jun 20, 2022
Agent entered
- Representative
- MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex
Published in Swissreg on 20.06.2022
- May 11, 2022
Granted
Published in Swissreg on 11.05.2022
Parties
Inventor
San Diego, CA 92127, US
San Diego, CA 92130, US
San Diego, CA 92130, US
San Diego, CA 92122-4647, US
San Diego, CA 92128, US
San Diego, CA 92111, US
Del Mar, CA 92014, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.